Etoposide Suppliers & Bulk Manufacturers
Available Forms: Oral Capsules & Injection:
Available Strengths: Injection: 20 mg/mL; Capsule: 50 mg
Reference Brands: US: Toposar® (injection) VePesid® (capsules); EU: Etopophos® (injectable phosphate form) Vepesid® (capsules)
Category: Oncology Cancer Care
Etoposide is available in Oral Capsules & Injection: and strengths such as Injection: 20 mg/mL; Capsule: 50 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Etoposide is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Etoposide can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description: Etoposide is a potent oncology agent available in the US and EU, widely used to treat small cell lung cancer, testicular cancer, and various hematologic malignancies. Available as 20 mg/mL injection and 50 mg oral capsules, Etoposide disrupts DNA replication by inhibiting topoisomerase II, leading to cancer cell death. Sold under brand names like Toposar®, VePesid®, and Etopophos®, and as numerous generics, it remains a cornerstone in combination chemotherapy protocols. Etoposide is a trusted and essential option in hospital procurement and pharmaceutical B2B supply chains across regulated markets.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Crinecerfont
Strength:
50 mg, 100 mg, 50 mg/mL
Form: Capsule / Oral solution
Reference Brands: Crenessity (USA)
View Details
Quick Response Guaranteed | Verified Suppliers
